Nov 04, 11 10:00AM
|
0 comments
For patients with coronary heart disease (CHD), and atherosclerotic vascular disease, health care practitioners should implement appropriate treatment based on evidence-based guidelines and assess their success, according to a scientific statement published online Nov. 3 in Circulation.
Sidney C. Smith Jr., M.D., from the University of North Carolina at Chapel Hill, and colleagues reviewed available literature to update the 2006 American College of Cardiology Foundation and the American Heart Association guidelines on secondary prevention and risk reduction therapy for patients with CHD, and atherosclerotic vascular disease.

Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.